Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get trading ideas, historical data, advanced options screeners, more. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Organon & Co. (OGN)
Organon & Co. (OGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,983,912
  • Shares Outstanding, K 255,062
  • Annual Sales, $ 6,174 M
  • Annual Income, $ 917,000 K
  • 60-Month Beta 0.77
  • Price/Sales 0.82
  • Price/Cash Flow 3.38
  • Price/Book N/A
Trade OGN with:

Options Overview Details

View History
  • Implied Volatility 35.06% ( +3.41%)
  • Historical Volatility 35.78%
  • IV Percentile 56%
  • IV Rank 35.00%
  • IV High 52.74% on 10/13/22
  • IV Low 25.54% on 08/17/22
  • Put/Call Vol Ratio 0.28
  • Today's Volume 503
  • Volume Avg (30-Day) 536
  • Put/Call OI Ratio 0.60
  • Today's Open Interest 18,130
  • Open Int (30-Day) 18,258

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/23
See More
  • Average Estimate 1.01
  • Number of Estimates 5
  • High Estimate 1.04
  • Low Estimate 0.95
  • Prior Year 1.25
  • Growth Rate Est. (year over year) -19.20%

Price Performance

See More
Period Period Low Period High Performance
1-Month
19.15 +2.04%
on 05/25/23
24.79 -21.18%
on 05/01/23
-4.16 (-17.55%)
since 04/26/23
3-Month
19.15 +2.04%
on 05/25/23
26.17 -25.32%
on 02/27/23
-6.05 (-23.64%)
since 02/24/23
52-Week
19.15 +2.04%
on 05/25/23
38.95 -49.83%
on 05/27/22
-19.02 (-49.33%)
since 05/26/22

Most Recent Stories

More News
Stocks Finish Higher as Negotiators Inch Toward a Debt-Ceiling Agreement

What you need to know… The S&P 500 Index ($SPX ) (SPY ) Friday closed up +1.30%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +1.00%, and the Nasdaq 100 Index ($IU XX) (QQQ ) closed up +2.58%....

$SPX : 4,205.45 (+1.30%)
SPY : 420.02 (+1.30%)
$DOWI : 33,093.34 (+1.00%)
DIA : 330.84 (+0.94%)
$IUXX : 14,298.41 (+2.58%)
QQQ : 348.40 (+2.56%)
NVDA : 389.46 (+2.54%)
KLAC : 461.19 (+6.20%)
GFS : 60.05 (+6.45%)
QCOM : 110.35 (+6.09%)
MU : 73.93 (+6.21%)
MCHP : 78.32 (+5.64%)
ORGANON CANADA TO SUPPORT LE CHAÎNON BY FUNDING THE INITIAL CONSTRUCTION PHASE OF ITS MEDICAL CLINIC

/CNW/ - As part of Le Chaînon's 90th anniversary, Organon Canada, a subsidiary of Organon (NYSE: OGN), a global women's health company, is announcing a...

OGN : 19.54 (-1.61%)
Media Advisory - Organon Canada to announce funding in support of women's shelter Le Chaînon, as well as the unveiling of a space at Organon Canada's offices in honour of Ms. Maisonneuve, founder of Le Chaînon

/CNW/ - As part of Le Chaînon's 90th anniversary, Organon Canada, a subsidiary of Organon (NYSE: OGN), a global women's health company, will be announcing on...

OGN : 19.54 (-1.61%)
Stocks Tumble as Liquidity Concerns Rout Regional Bank Stocks

What you need to know… The S&P 500 Index ($SPX ) (SPY ) Thursday closed down -0.72%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.86%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed...

$SPX : 4,205.45 (+1.30%)
SPY : 420.02 (+1.30%)
$DOWI : 33,093.34 (+1.00%)
DIA : 330.84 (+0.94%)
$IUXX : 14,298.41 (+2.58%)
QQQ : 348.40 (+2.56%)
PACW : 7.11 (+4.41%)
WAL : 35.52 (+0.25%)
FHN : 10.88 (-0.18%)
CMA : 38.99 (-0.51%)
ZION : 28.66 (+1.20%)
KEY : 9.89 (-2.18%)
Stocks Undercut as Regional Bank Stocks Plunge

What you need to know… The S&P 500 Index ($SPX ) (SPY ) today is down -0.70%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -1.00%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.34%....

$SPX : 4,205.45 (+1.30%)
SPY : 420.02 (+1.30%)
$DOWI : 33,093.34 (+1.00%)
DIA : 330.84 (+0.94%)
$IUXX : 14,298.41 (+2.58%)
QQQ : 348.40 (+2.56%)
PACW : 7.11 (+4.41%)
WAL : 35.52 (+0.25%)
CMA : 38.99 (-0.51%)
ZION : 28.66 (+1.20%)
KEY : 9.89 (-2.18%)
CFG : 27.01 (+0.60%)
Organon (OGN) Reports Q1 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for Organon (OGN) give a sense of how the business performed in the quarter ended March 2023, it could be worth looking at how some of its key metrics compare to...

OGN : 19.54 (-1.61%)
Organon Reports Results for the First Quarter Ended March 31, 2023

Organon (NYSE: OGN) today announced its results for the first quarter ended March 31, 2023.

OGN : 19.54 (-1.61%)
Establishment Labs Holdings Inc. (ESTA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Establishment Labs Holdings Inc. (ESTA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

ESTA : 64.85 (-0.06%)
OGN : 19.54 (-1.61%)
Organon To Report First Quarter and Host Conference Call on May 4, 2023

Organon (NYSE: OGN), a global women’s healthcare company will release its first quarter 2023 financial results on May 4, 2023, prior to the company’s webcast and conference call scheduled for 8:30...

OGN : 19.54 (-1.61%)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Organon & Co. - OGN

/PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Organon & Co. ("Organon" or the "Company") (NYSE: OGN). Such investors are...

OGN : 19.54 (-1.61%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Organon is a healthcare company. It focuses on the health of women throughout their lives. Organon is based in JERSEY CITY, N.J.

See More

Key Turning Points

3rd Resistance Point 20.60
2nd Resistance Point 20.35
1st Resistance Point 19.94
Last Price 19.54
1st Support Level 19.28
2nd Support Level 19.03
3rd Support Level 18.62

See More

52-Week High 38.95
Fibonacci 61.8% 31.39
Fibonacci 50% 29.05
Fibonacci 38.2% 26.71
Last Price 19.54
52-Week Low 19.15

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar